{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001326110","name":"ImmunityBio, Inc.","summary":"ImmunityBio, Inc. (IBRX) is a clinical-stage biopharmaceutical company focused on developing next-generation therapies and vaccines that harness the immune system to combat cancers and infectious diseases. Its approved product, ANKTIVA, is commercialized for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC). The company's Cancer BioShield platform encompasses cytokine fusion proteins, DNA and recombinant protein vaccines, and cell therapies including NK cell-based treatments.","people":[],"products":[{"name":"ANKTIVA","type":"platform","description":"FDA-approved cytokine fusion protein for BCG-unresponsive NMIBC; also in development for NSCLC and other indications."},{"name":"PD-L1 t-haNK","type":"platform","description":"NK cell-based therapy candidate targeting PD-L1, part of the taNK cell therapy program."},{"name":"M-ceNK","type":"platform","description":"Next-generation NK cell therapy product candidate in development."},{"name":"hAd5 constructs","type":"platform","description":"DNA/recombinant protein vaccine candidates in clinical development."},{"name":"NK-CAR (t-haNK)","type":"platform","description":"CAR-NK cell therapy candidate leveraging chimeric antigen receptor technology."},{"name":"Cancer BioShield Platform","type":"platform","description":"Multiple therapeutic modalities designed to activate immune response against cancers and infectious diseases."}],"partnerships":[{"partner_name":"International partners (EU and MENA regions)","partnership_type":"strategic","description":"International partners engaged to drive commercialization of ANKTIVA in the EU and MENA regions.","start_date":null}],"affiliations":[],"origin":{"leaf":"e9589f079d62016c5333349711e0ad67c069ae3b054488a3dedc459dafe3e880","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"b259d669e0f619a043ecabb651ff660c0065326bc9168c8279dedc6194cc12fd","parent":"935e880fde80e13fddad46674146d273c914496368a04197ed7723a48ea54094","source":"0001326110-26-000030","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":74,"hourly_limit":500,"remaining":426,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}